AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Shantroz 2.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Shantha Biotech

Salt Composition

Letrozole (2.5mg)

Overview Shantroz 2.5mg Tablet

Postmenopausal women with breast cancer may find relief with Shantroz 2.5mg tablets. This medication can be administered independently or alongside other therapies like surgery or radiotherapy. In advanced breast cancer, it aids in preventing metastasis. Shantroz 2.5mg tablets may be consumed with or without food, always adhering to the physician's prescribed dosage and duration for optimal results. Dosage and frequency are tailored to individual needs. Your doctor will determine the appropriate amount to manage your symptoms. Continue taking this medication for the prescribed period. Common side effects include increased sweating, hot flashes, fatigue, and elevated cholesterol. Report any concerning side effects to your physician, who can offer management strategies. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, osteoporosis, or other medications you're currently using, as interactions may impact efficacy. Disclose pregnancy or breastfeeding status to your doctor. Blood tests to assess vitamin D levels and bone density may be conducted before and during treatment.

Primary Ingredients of Shantroz 2.5mg Tablet

No text provided to rephrase.

Uses of Shantroz 2.5mg Tablet

Managing breast cancer

Major Benefits of Shantroz 2.5mg Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Shantroz 2.5mg Tablets can be administered with or without food, although consistent timing is recommended.

Common Side effects of Shantroz 2.5mg Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Shantroz 2.5mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Shantroz 2.5mg Tablets can be consumed with or without food, however, consistent daily timing is recommended.

How Shantroz 2.5mg Tablet works:

Estrogen production is reduced by Shantroz 2.5mg Tablets, an aromatase inhibitor. This reduction in the body's estrogen levels can inhibit or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse reactions from concomitant use of Shantroz 2.5mg Tablet and alcohol.

PregnancyPregnancyUNSAFE

Using Shantroz 2.5mg tablets during pregnancy is strongly contraindicated. Pregnant women should consult their physician; research in both animals and humans indicates substantial risks to fetal development.

Breast feedingBreast feedingUNSAFE

Lactation and Shantroz 2.5mg tablets are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Taking Shantroz 2.5mg Tablets might reduce awareness, impair vision, and cause drowsiness or dizziness. Driving is inadvisable if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

For individuals with kidney disease, Shantroz 2.5mg tablets are considered safe, and no dosage alteration is typically necessary. Limited data exists, however, regarding its use in patients with end-stage renal disease. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Shantroz 2.5mg tablets. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Shantroz 2.5mg Tablet :

Should you forget a Shantroz 2.5mg Tablet dose, take it immediately. If, however, your next dose is nearly due, omit the missed dose and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Shantroz 2.5mg Tablet

LabelValue
Chemical Type Diphenylmethane-based compound
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Shantroz 2.5mg Tablet

Shantroz 2.5mg tablets are aromatase inhibitors used to treat breast cancer in postmenopausal women.
Shantroz 2.5mg tablets are anti-estrogens. They work by inhibiting aromatase, an enzyme that produces estrogen. Lowering estrogen levels helps control estrogen-dependent breast cancers, thereby hindering their growth.
For advanced breast cancer or cancer that has spread, continue taking Shantroz 2.5mg Tablet until tumor progression. Following tamoxifen or surgery, take Shantroz 2.5mg Tablet for five years, or until recurrence, whichever occurs first. Alternatively, a sequential regimen of two years of Shantroz 2.5mg Tablet followed by three years of tamoxifen may be used.
While irbesartan and Shantroz 2.5mg Tablet can be taken together, monitor your blood pressure closely as Shantroz 2.5mg Tablet may raise it. Consult your doctor if blood pressure management becomes difficult.
While rare, Shantroz 2.5mg Tablets may cause cataracts. Seek immediate medical attention if you develop blurred vision or eye irritation.
Experiencing hot flushes may indicate a common Shantroz 2.5mg Tablet side effect, linked to decreased estrogen. These usually lessen as your body adapts, but may persist throughout treatment, subsiding within months after completion. Consult your doctor if hot flushes are severe.
Shantroz 2.5mg Tablet rarely causes serious side effects, which may include stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions.
Shantroz 2.5mg Tablets can weaken bones (osteoporosis) by lowering estrogen levels. Your doctor may monitor your bone density before, during, and after treatment to check for this.
The Ministry of Health and Family Welfare restricts Shantroz 2.5mg Tablets to ovulation induction for treating anovulatory infertility.
Shantroz 2.5mg Tablet
254